Login
← Go Back
Gufic Biosciences
GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com
Stock Price vs Company Growth
1d
0.6%
1w
3.0%
1m
6.9%
3m
1.9%
6m
38.5%
1y
15.3%
5y
16.3%
10y
25.5%
all
20.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 405 0.6%
368
466
Company Overview
Sales
981 Cr
Growth: 13.5%
Profit after Tax
73.5 Cr
Growth: 14.4%
Small Cap
4,065 Cr
P/E: 55.4x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 981
Growth 13.5%
EBITDA 16.8%
P/S 4.1x
Dividend 0.0%
P/E 55.4x
Book Value ₹ 68.5
PEG Ratio 4.1x
ROE 11.2%
P/B 5.9x
Shareholding Pattern
Institutions
Sbi Healthcare Opportunities Fund
2.61 %
Promoters
Mr. Jayesh P. Choksi
25.95 %
Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)
21.17 %
Gufic Private Limited
10.51 %
Mr. Pranav J. Choksi
7.5 %
Others
Vipula Jayesh Choksi
10.35 %
Jagdish N Master
1.65 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.
Belongs to (9 Indices) view more
Investors (45)
icici.pr...
finco.ca...
sbi.acti...
Followers (8)
indrajee...
nihal
mrinmoy4